Skip to main content
Signal8

KANOVSKY STEPHEN M

SEC insider (Form 3/4/5 filer). CIK 0001713090. Director at NEOGENOMICS INC (NEO). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in FORT MYERS, FL.

Companies KANOVSKY STEPHEN M has filed insider reports for

  • NEOGENOMICS INC (NEO): Director
KANOVSKY STEPHEN M profile photo

KANOVSKY STEPHEN M

CIK: 0001713090

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NEOGENOMICS INC logo
NEO

NEOGENOMICS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    11.1K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2026
    Exercise
    Direct
    23.1K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2026
    Award

    Restricted Stock Unit

    Direct
    16K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16.1K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2025
    Award

    Restricted Stock Unit

    Direct
    23.1K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    Jun 1, 2025
    Exercise
    Direct
    12.3K shares-
  • NEOGENOMICS INC logo
    NEO

    NEOGENOMICS INC

    May 7, 2025
    Purchase
    Direct
    4K shares at avg. $7.78$31K

1-7 of 7